₨ 85,000
The Opdivo (Nivolumab) 100 mg/10 mL, is an immunotherapy medication used to treat various types of cancer.
Medication Details
- Brand Name: Opdivo
- Generic Name: Nivolumab
- Strength: 100 mg/10 mL
- Form: Solution for intravenous infusion
- Manufacturer: Bristol-Myers Squibb
- Usage: It is a prescription drug used to help the immune system fight cancer cells and is approved for several types of cancer, including melanoma, non-small cell lung cancer, kidney cancer, head and neck cancer, and more.
Important Safety Information
- Opdivo can cause immune-mediated adverse reactions, which means it can cause your immune system to attack normal organs and tissues in any area of your body.
- Possible side effects can include fatigue, rash, diarrhea, nausea, musculoskeletal pain, and potentially severe issues like inflammation of the lungs (pneumonitis), liver (hepatitis), or kidneys (nephritis).
- It is administered by a healthcare professional in a hospital or clinic setting.
Disclaimer: This information is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional regarding any medical conditions, treatments, or side effects.
₨ 10,000
